Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin.
about
The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureusReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsOritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive InfectionsDifferent bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia.Combination prophylactic therapy with rifampin increases efficacy against an experimental Staphylococcus epidermidis subcutaneous implant-related infectionThe epidemiology of Staphylococcus aureus carriage in patients attending inner city sexually transmitted infections and community clinics in Calgary, Canada.Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")Purification and activity testing of the full-length YycFGHI proteins of Staphylococcus aureus.tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus.The msaABCR operon regulates resistance in vancomycin-intermediate Staphylococcus aureus strains.Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibilityIn vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.Vancomycin tolerant, methicillin-resistant Staphylococcus aureus reveals the effects of vancomycin on cell wall thickeningSpatio-temporal remodeling of functional membrane microdomains organizes the signaling networks of a bacterium.Vancomycin-intermediate Staphylococcus aureus strains have impaired acetate catabolism: implications for polysaccharide intercellular adhesin synthesis and autolysisGenetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300.Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in miceCombinatory antibiotic therapy increases rate of bacterial kill but not final outcome in a novel mouse model of Staphylococcus aureus spinal implant infectionβ-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.Spontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus.Vancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections.Comparative proteomics-based identification of genes associated with glycopeptide resistance in clinically derived heterogeneous vancomycin-intermediate Staphylococcus aureus strains.Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.Draft Genome Sequences of Three Northern German Epidemic Staphylococcus aureus (ST247) Strains Containing Multiple Copies of IS256.A current perspective on daptomycin for the clinical microbiologist.Vancomycin-rifampin combination therapy has enhanced efficacy against an experimental Staphylococcus aureus prosthetic joint infection.Acquired vancomycin resistance in clinically relevant pathogens.Polymeric nanofiber coating with tunable combinatorial antibiotic delivery prevents biofilm-associated infection in vivoA potential role of transposon IS431 in the loss of mecA geneEmergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycin.First report of vancomycin-resistant staphylococci isolated from healthy carriers in BrazilPhenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis.Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate- S. aureus-type resistance to vancomycin.Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.Lack of evidence for involvement of hypermutability in emergence of vancomycin-intermediate Staphylococcus aureus.Antibiotic-induced autoactivation of IS256 in Staphylococcus aureus.Strain-specific expression levels of pbp4 exist in isolates of glycopeptide-intermediate Staphylococcus aureus (GISA) and heterogeneous GISA.
P2860
Q21263072-0C465D4F-81FC-4452-A527-E1DB4D84FBBFQ24646677-6CD9FE2A-485D-435E-A8A7-10922FE7D27DQ26772897-2C9CEA8A-B1AD-49DC-BF9A-7B8AA1047FA3Q33321447-97127799-1387-4DE1-A39B-5C1626378D29Q33622963-35A33B64-8863-473A-AD0D-4B6634EAC5C2Q33728644-22209E38-6AEA-4EC2-B7AF-71EF20CBDBCFQ34045273-A0AC4EC5-F4CF-409B-928E-A91219F77F39Q34140571-87EB962D-2391-493C-B1F5-5B94403B888DQ34141289-D0A55DD5-173A-40EE-BB94-022A2B32FBACQ34596835-484B8B8F-4D1E-465E-8F2F-CB504CA0069DQ34632683-3444415C-9D56-4E76-9C0A-7974B7890D34Q34721614-DF84DC6E-4376-49F1-A0D0-AFE52A6621A8Q35023285-696F7115-6EE6-4BEB-84BB-E32EE68D92C8Q35203343-C6BAA1AB-2E17-433F-8A6A-EC0F1AB44CBFQ35613529-4E8209D5-D11F-47BC-8B9E-3FCC01076857Q35635966-B53A7C3A-5B04-4889-83C2-01A06F6C3E4EQ35728976-33F16923-24A3-475D-B437-4993693433C2Q35941476-5FADDF1B-E2E9-477A-86F5-FD2CA3F58AFAQ36292752-E54AF61C-C18F-4011-B0EC-DACB57FB7628Q36396117-260DCEBF-A985-402F-96E1-50AE26A3D1F4Q36538634-31A8CC5F-2736-48C0-82D2-AAD1033F1CDEQ36847287-1ED6751E-3F56-4261-9466-F9E70CE798B7Q36964857-F976D8C9-0859-4722-9A76-0D17A9CC6DEFQ37156698-DDFE0898-A957-4059-A86F-622A56BDE0FCQ37244422-D886D770-33A3-451F-8661-B60F36FE7E25Q37263289-6193F284-1FCB-4EE4-A8CE-2AAD4D130E44Q37263918-2ED0C998-65C5-41A8-8B78-016CB525A589Q37277083-87B74E5E-5824-44CC-AD18-D0554C1A3AF1Q37417976-3AD7346C-044B-4E27-974A-E1B606D8292AQ37605175-F7883499-F8E9-434D-BCCF-E0022BB57161Q40758601-D40EA152-AC8B-4AC1-BA31-E6826E763637Q40771872-8765C2C2-A4CB-4B3A-ABCB-95A15ECFDA89Q40896611-19C39013-0801-4D45-B28D-7D03CAA70EEBQ41005454-06A79520-09AD-4C4A-9EE2-574CA5F346DEQ41867637-9E342193-E9FD-4FB7-BD70-6464A1022B1EQ42111665-0EABB8ED-A1B5-41E6-8498-4500CD20ABBFQ42112516-72471C7A-E20A-4C6A-BB9F-407D3F815CE6Q42859651-99310B8F-000E-4F45-A4CD-3A7C081F0F0AQ42872183-0DC4F4CE-5774-4BEF-8589-BBA632CB7B9BQ42949210-641759F7-F8F7-4F62-8CF0-70FF99BA2E53
P2860
Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Morphological and genetic diff ...... usceptibilities to vancomycin.
@ast
Morphological and genetic diff ...... usceptibilities to vancomycin.
@en
Morphological and genetic diff ...... usceptibilities to vancomycin.
@nl
type
label
Morphological and genetic diff ...... usceptibilities to vancomycin.
@ast
Morphological and genetic diff ...... usceptibilities to vancomycin.
@en
Morphological and genetic diff ...... usceptibilities to vancomycin.
@nl
prefLabel
Morphological and genetic diff ...... usceptibilities to vancomycin.
@ast
Morphological and genetic diff ...... usceptibilities to vancomycin.
@en
Morphological and genetic diff ...... usceptibilities to vancomycin.
@nl
P2093
P2860
P1476
Morphological and genetic diff ...... usceptibilities to vancomycin.
@en
P2093
Andrea Reipert
Gabriele Bierbaum
Kerstin Ehlert
Thomas Kast
P2860
P304
P356
10.1128/AAC.47.2.568-576.2003
P407
P577
2003-02-01T00:00:00Z